Drug-labels.com

Bosulif (Pfizer Canada, 100 mg, 500 mg): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
100 mg, 500 mg
ATC code:

Patient Medication Information: uses, side effects, how to take - Bosulif (Pfizer Canada, 100 mg, 500 mg)

Serious warnings and precautions box

What BOSULIF is used for:

BOSULIF is used to treat:

  • adults who have a new diagnosis of a white blood cell cancer called Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in a chronic phase or
  • adults who have Ph+ CML in a chronic, accelerated, or blast phase (the blood cancer grows faster in accelerated or blast than in chronic phase) and for whom previous medicines to treat Ph+ CML have either not worked or not been suitable.

A qualified healthcare professional experienced in the use of anticancer therapies and in the treatment of CML should prescribe BOSULIF.

BOSULIF is NOT recommended for use in children less than 18 years of age.

How BOSULIF works:

BOSULIF works by slowing down the growth and spread of cancer cells in patients with CML.

The ingredients in BOSULIF are:

Medicinal ingredients: bosutinib

Serious side effects with BOSULIF include:

  • Drug interactions with inhibitors or inducers of CYP3A4 enzyme. Do NOT use BOSULIF with strong and moderate CYP3A4 inhibitors and inducers (see Serious Drug and Drug-Food Interactions below)
  • Gastrointestinal problems (vomiting and diarrhea)
  • Liver problems
  • Heart problems that may lead to death
  • Fluid in the lungs and around the heart (fluid retention)
  • Bleeding
  • Abnormal electrical signal of the heart

Non-medicinal ingredients: croscarmellose sodium, iron oxide yellow (for 100 mg tablet), iron oxide red (for 500 mg tablet), magnesium stearate, microcrystalline cellulose, poloxamer, polyethylene glycol, polyvinyl alcohol, povidone, talc, and titanium dioxide

BOSULIF comes in the following dosage forms:

Tablets: 100 mg and 500 mg

Do not use BOSULIF if:

  • you are allergic to bosutinib or any of the other ingredients of BOSULIF
  • you have an abnormal electrical signal of the heart (prolongation of QT interval)
  • you have uncorrectable low levels of potassium or magnesium
  • you have liver problems (such as liver failure)

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take BOSULIF. Talk about any health conditions or problems you may have, including if you:

  • have or have had a liver problem.
  • have or have had a heart problem.
  • have or have had a pancreas problem.
  • have or have had a kidney problem.
  • have gastrointestinal problems (vomiting and diarrhea).
  • have or have had in the past, a hepatitis B virus infection (a viral infection of the liver). This is because during treatment with BOSULIF, hepatitis B may become active again which can lead to death in some cases. Your doctor will test for signs of this infection before treatment with BOSULIF and while on treatment if required.

Other warnings you should know about:

Female patients:

Pregnancy and birth control

  • If you are pregnant or plan to become pregnant, there are specific risks you should discuss with your healthcare professional.
  • Do NOT become pregnant while taking BOSULIF. It may cause harm to your unborn child.
  • Use highly effective birth control during treatment and for at least one month after your last dose of BOSULIF.
  • Tell your healthcare professional right away if you become pregnant.

Breast-feeding

  • BOSULIF may pass into your breast milk and harm your baby.
  • Do NOT breast-feed during treatment with BOSULIF.
  • Talk to your healthcare professional about the best way to feed your baby during treatment with BOSULIF.

Male patients:

  • Use highly effective birth control each time you have sex with a woman who is pregnant, may be pregnant or could become pregnant. Continue using birth control for at least 4 weeks after the last dose of BOSULIF.
  • Tell your healthcare professional right away if your sexual partner becomes pregnant.

Fertility:

Treatment with BOSULIF may affect your ability to have children in both male and female patients. Talk to your healthcare professional if this is a concern for you.

Driving and using machines:

Before engaging in tasks that require special attention, wait until you know how you respond to BOSULIF. Do NOT drive or use machines if you feel tired, dizzy, or experience any changes in vision while taking BOSULIF.

Monitoring and laboratory tests:

Your healthcare professional will regularly monitor and assess your health before and while you are taking BOSULIF. This may include blood tests, urine tests and ECG recording.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

Serious drug and drug-food interactions:

Do NOT take any products or juice containing grapefruit, star fruit, pomegranate, Seville oranges or similar fruits while taking BOSULIF. They may change the amount of BOSULIF in your body.

While taking BOSULIF, avoid taking drugs that are used to:

  • treat fungal infections such as ketoconazole, itraconazole, voriconazole, posaconazole, and fluconazole
  • treat human immunodeficiency virus (HIV) infections such as lopinavir/ritonavir, atazanavir, indinavir, nelfinavir, saquinavir, darunavir/ritonavir, amprenavir, efavirenz, etravirine and fosamprenavir.
  • treat high blood pressure such as dialtiazem, verapamil, bosentan and mibefradil
  • treat depression such as nefazodone and St. John’s wort (a herbal preparation obtained without a prescription)
  • treat bacterial infections such as erythromycin, clarithromycin, ciprofloxacin and nafcillin
  • treat tuberculosis such as rifampicin
  • treat epilepsy such as phenytoin and carbamazepine
  • prevent and control nausea (feeling sick) and vomiting, such as aprepitant
  • treat certain types of sleep disorders, such as modafinil
  • treat cancers, such as crizotinib and imatinib
  • treat hepatitis C virus, such as telaprevir
  • treat low sodium, such as conivaptan

The following may also interact with BOSULIF:

  • Vandetanib, sunitinib, nilotinib, lapatinib (other cancer medicines).
  • Quinidine, amiodarone and other medicines for heart rhythm problems (anti-arrhythmic medicines).
  • Lansoprazole, dexlansoprazole, omeprazole, esomeprazole, pantoprazole, rabeprazole (medicines for reducing stomach acid).
  • Amitryptiline and imipramine (medicine for depression).
  • Pimozide, ziprasidone, haloperidol (medicine for psychoses).
  • Quinine and chloroquine (medicine to treat malaria).
  • Domperidone, dolasetron and ondansetron (medicine for nausea and vomiting).
  • Formoterol and salmeterol (asthma medicines).
  • Water pills, laxatives (medicine that decrease electrolyte levels).

Know the medicines you take. Keep a list of your medicines, both prescription and non-prescription, and show it to your doctor and pharmacist when you get a new medicine. Do NOT take other medicines with BOSULIF until you have discussed with your doctor.

How to take BOSULIF:

  • Always take BOSULIF exactly as your healthcare professional has told you. Check with your doctor or pharmacist if you are not sure.
  • BOSULIF should be taken with a meal.
  • Swallow BOSULIF tablets whole. Do NOT cut, crush or dissolve the tablets.
  • Do NOT drink grapefruit juice or eat grapefruit, grapefruit products, star fruit, pomegranate, Seville oranges and other similar fruits. They may change the amount of BOSULIF in your body.

Usual dose:

Adults (18 years of age and older)

  • Patients with newly-diagnosed chronic phase Ph+ CML: 400 mg once daily.
  • Patients with chronic, accelerated, or blast phase Ph+ CML whose previous medicines to treat Ph+CML have either not worked or not been suitable: 500 mg once daily.

Your healthcare professional will monitor your health during treatment with BOSULIF. They may interrupt, change, or stop your dose. This may occur based on your current health, or if you experience certain side effects.

Overdose:

If you think you, or a person you are caring for, have taken too much BOSULIF, contact a healthcare professional, hospital emergency department, or regional poison control centre or Health Canada’s toll-free number, 1-844 POISON-X (1-844-764-7669) immediately, even if there are no symptoms.

If possible, show your healthcare professional the blister pack, or this leaflet. You may require medical attention.

Missed Dose:

If dose is missed by:

  • Less than 12 hours, take your recommended dose.
  • More than 12 hours, take your next dose at your regular time on the following day. Do not take a double dose to make up for the forgotten tablets.

Possible side effects from using BOSULIF:

These are not all the possible side effects that you may have when taking BOSULIF. If you experience any side effects not listed here, tell your healthcare professional.

  • Rash
  • Nasopharyngitis (common cold virus): sore throat combined with runny nose
  • Back pain
  • Dysgeusia (altered taste perception): persistent foul, salty, rancid, or metallic taste sensation in the mouth
  • Gastrointestinal toxicity: diarrhea, vomiting, stomach pain, nausea, and/or decrease of appetite
  • Gastritis (stomach inflammation): stomach irritation
  • Arthralgia (Joint pain): mild to severe pain, limited joint motion, locking of the joint, stiffness
  • Fatigue
  • Headache
  • Dizziness
  • Fever
  • Influenza (viral infection that affects the respiratory system): fever, body aches, fatigue
  • Bronchitis (inflammation of the bronchial tubes): cough, chest tightness, wheezing
  • Dehydration (excessive loss of body fluid)
  • Itching, urticaria (hives), acne (conditions affecting the skin)

Tell your doctor if you have any side effect that bothers you or that does not go away.

Serious side effects and what to do about them

Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking the drug and get immediate medical help
Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking the drug and get immediate medical help
Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking the drug and get immediate medical help
Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking the drug and get immediate medical help
Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking the drug and get immediate medical help
Only if severeIn all cases
Only if severeIn all cases
Only if severeIn all cases
Only if severeIn all cases
Only if severeIn all cases
Very Common
Myelosuppression (decrease in bone marrow activity resulting in fewer red blood cells, white blood cells, and platelets): fatigue, shortness of breath, dizziness, weakness, rapid breathing,
headache, bleeding, infections, and skin pallor
Dyspnea (difficulty breathing): shortness of breath, chest tightness
Changes in biochemical markers: used to determine if BOSULIF is affecting your liver, kidney, and/or pancreas (shown in test results)
Pleural effusion (fluid around the lungs): cough, shortness of breath, elevated respiration rate, and chest pain, heaviness, or tightness
Neutropenia (abnormally low number of neutrophils [a type of white blood cell] in the blood): fever, chills or sweating, sore throat, mouth sores, infections, cough, and difficulty breathing
Edema (fluid retention): Swelling of hands, feet or face
Common
Hypertension (high blood pressure): headache, nosebleed, fatigue or confusion, vision problems, shortness of breath, chest pain, difficulty breathing, and irregular heartbeat
Cardiac Failure (heart doesn't pump blood as efficiently as it should) shortness of breath, persistent cough, fatigue, nausea, dizziness, swelling of lower extremities, and rapid or irregular heartbeat
Cardiac Ischemic events (heart problems caused by narrowing of arteries that supply blood to the heart) Neck or jaw pain, shoulder or arm pain, chest pain or discomfort, rapid heartbeat, shortness of breath during physical activity, nausea, vomiting, sweating, and fatigue
Pancreatitis (inflammation of the pancreas): upper abdominal pain, fever, rapid heart beat, nausea, vomiting, tenderness when touching the abdomen
Pericardial effusion (accumulation of fluid around the heart): chest pain or discomfort, fainting, shortness of breath, nausea, elevated heart rate, elevated breathing rate, swelling of upper and lower extremities, pain in upper right abdomen
Renal failure, renal impairment (kidney failure, kidney impairment): decreased urine output, fluid retention, swelling of upper and lower extremities, shortness of breath, fatigue, nausea, weakness, and irregular heartbeat
Hepatotoxicity (liver injury or impairment of liver function): jaundice, abdominal pain in upper right abdomen, fatigue, loss of appetite, nausea, vomiting, rash, fever, weight loss, itching, and dark-coloured urine
Pneumonia (inflammation of the lungs caused by infection): cough which may produce green, yellow or bloody mucus, fever, chills, and difficulty breathing, shortness of breath, rapid, shallow breathing, chest pain that worsens with deep breathing or coughing, and fatigue
Hyperkalemia (abnormally high level of potassium in the blood): abdominal pain, diarrhea, chest pain, abnormal heartbeat, nausea, vomiting, and muscle weakness or numbness
Hypophosphatemia (abnormally lows level of phosphorous in the
blood): muscle weakness, fatigue, bone pain and fractures, numbness, confusion, respiratory failure, heart failure, seizures, and coma
Respiratory failure (lack of oxygenated blood leading to respiratory failure): dizziness, difficulty breathing or shortness of breath, rapid breathing, fatigue, elevated heart rate, wheezing, and cyanosis
Pulmonary hypertension (high blood pressure in the blood vessels leading from the heart to the lungs): shortness of breath, dizziness, chest pain/pressure, irregular heartbeat, fatigue, swelling in the upper and lower extremities, and cyanosis
Gastrointestinal hemorrhage (bleeding in the stomach or intestine): black, tarry, or bright red stool, blood in vomit, abdominal cramps, dizziness, fatigue, skin pallor, shortness of breath, and weakness
Long QT syndrome (abnormal heartbeat): dizziness, heart palpitations, loss of consciousness, cardiac arrest, and seizures
Uncommon
Pericarditis (inflammation of the sac-like structure surrounding the heart): chest pain, cough, elevated heart rate, irregular heart rate, fever, shortness of breath, weakness, and fatigue
Anaphylactic shock (severe potentially life-threatening allergic reaction): dizziness, difficulty breathing and shortness of breath, rapid breathing, cyanosis, nausea or vomiting, elevated heart rate,
tongue swelling, difficulty swallowing, facial swelling, and confusion
Erythema multiforme (severe inflammatory skin reaction): exfoliative (scaly, peeling) skin eruptions, fever, headache, mouth sores, fatigue, pruritus, and joint pain
Interstitial lung disease (disorders causing scarring in the lungs): Cough, difficulty breathing, painful breathing
Bone fracture (broken bone): area around break will be painful and swollen, bulge or bump at site of break
Cutaneous vasculitis (inflammation of blood vessels of the skin): tiny red/purple dots that can be flat or raised/bumps, persistent hives, pus (yellow) filled bumps, firm lumps, open areas of skin that is moist and red, or net-like purple pattern on skin✓
Rare
Stevens-Johnson syndrome (severe skin reaction): fever, sore mouth/throat, cough, muscle aches, pruritus, severe red rash that blisters/peels with mouth sores and painful, red, watery eyes
Unknown
Hepatitis B (liver infection) virus reactivation: this occurs when a previous hepatitis B infection becomes active again, which can be fatal in some cases. Symptoms include jaundice, abdominal pain in upper right abdomen, fatigue, loss of appetite, nausea, vomiting, rash, fever, weight loss, itching, and dark-coloured urine

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (canada.ca/drug-device-reporting) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Store at 20°C to 25°C.

Keep out of the reach and sight of children.

If you want more information about BOSULIF:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes the Patient Medication Information by visiting the Health Canada Drug Product Database website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html; the manufacturer’s website www.pfizer.ca, or by calling 1-800-463-6001.

Date of Authorization: 2026-06-02

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02419149

Approved according to the text: June 2, 2026

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Bosulif (Pfizer Canada, 100 mg, 500 mg)

Rx or OTC
Prescription (Rx)?
DIN 02419149, 02419157
Schedule(s) PRESCRIPTION
Active ingredient(s) Bosutinib (bosutinib monohydrate)
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. L Antineoplastic and immunomodulating agents
    1. L01 Antineoplastic agents
      1. L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents
        1. L01EA BCR-ABL tyrosine kinase inhibitors
          1. L01EA04 Bosutinib
Company PFIZER CANADA ULC
Current status Marketed
Strengths and forms
DIN Strength Dosage form(s) Current status
02419149 100 MG Tablet Marketed April 24, 2014
02419157 500 MG Tablet Marketed March 24, 2014

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.